dc.contributor.author | Hanimoglu, Hakan | |
dc.contributor.author | Tanriverdi, Taner | |
dc.contributor.author | Kacira, Tibet | |
dc.contributor.author | Kucur, Mine | |
dc.contributor.author | Canbaz, Bulent | |
dc.contributor.author | Kemerdere, Rahsan | |
dc.date.accessioned | 2021-03-03T19:18:50Z | |
dc.date.available | 2021-03-03T19:18:50Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Kemerdere R., Kacira T., Hanimoglu H., Kucur M., Tanriverdi T., Canbaz B., "Tissue and Plasma Thioredoxin Reductase Expressions in Patients with Glioblastoma Multiforme", JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, cilt.74, sa.4, ss.234-238, 2013 | |
dc.identifier.issn | 2193-6315 | |
dc.identifier.other | av_53dd9dba-bb40-444c-9739-fc6c6087d4a1 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/59435 | |
dc.identifier.uri | https://doi.org/10.1055/s-0032-1333422 | |
dc.description.abstract | Background and Study Aims Thioredoxin reductase (TrxR) is a redox protein that is considered to play a role in tumor progression. The purpose of this study was to assess the expression of TrxR in blood and tumor samples of glioblastoma multiforme (GBM) patients. | |
dc.language.iso | eng | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Tıp | |
dc.subject | Nöroloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | CERRAHİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Tissue and Plasma Thioredoxin Reductase Expressions in Patients with Glioblastoma Multiforme | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 74 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 234 | |
dc.identifier.endpage | 238 | |
dc.contributor.firstauthorID | 89795 | |